Publisher
Peertechz Publications Private Limited
Reference17 articles.
1. 1. Tefferi A, Patnaik MM, Pardanani A (2006) Eosinophilia: secondary, clonal and idiopathic. Br J Haemat 133: 468-492. Link: https://goo.gl/6frWC3
2. 2. Bain BJ, Fletcher SH (2007) Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 27: 377-388. Link: https://goo.gl/x2nO0D
3. 3. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, et al. (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130: 607-612. Link: https://goo.gl/JST22V
4. 4. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypersosinophilic syndrome. N Engl J Med 348: 1201-1214. Link: https://goo.gl/ZvnHz7
5. 5. Liu YY, Hill RA, Li YT (2013) Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv Cancer Res 117: 59-89. Link: https://goo.gl/SlMI5c